There are not many cells in the human body that survive for the lifetime of the individual. Many are replaced continuously -red blood cells, for example, last about 120 days, meaning that we each have to generate over 10 billion replacements every day. Some tissues replace their cells more slowly than this but can respond quickly if necessary. Mature lymphocytes, for example, are longlived, lasting up to ten years, but the ability to generate more on demand is nevertheless essential if a person is to avoid being overcome by the next passing infection. The production of new cells in the adult is ultimately attributable to stem cells [1] . These are characterized as quiescent or slow-growing cells that can generate quickly dividing cells -often called 'progenitor' or 'transient' cells -in response to normal attrition or injury. The progenitor cells expand quickly and replace the missing populations, leaving the stem cells in place to respond next time they are called upon.
In terms of stem cells, the brain, as in many things, has long been considered an exception. Your nerve cells do have to last your whole life -injure your brain and the loss of neurons is permanent. The best the brain will manage is to fill in the loss with glial cells. Teleological explanations of this fact often refer to the difficulty of attempting to wire replacement cells into the complexity of the adult brain. But the simple fact is that mature neurons cannot divide, and the adult brain has no stem cells, or so it appeared. One of the most exciting recent developments in neurobiology is the discovery that the adult nervous system does have multipotential stem cells with many of the properties that characterize the stem cells of the skin and the haematopoietic system. The key to this finding is a structure called the subependyma (see Fig. 1 ). In the embryonic brain, the neurons and glial cells that will comprise the adult brain are generated from neuroepithelial cells, the immediate descendents of the cells of the neural tube. These cells line the embryonic ventricles in what is called the ventricular zone, but later in embryonic development, some of them move deeper into the brain tissue to form the sub-ventricular zone, and it is this population that survives into the adult as the subependyma. It has been known for at least thirty years that this structure contains cells that divide routinely, unlike the surrounding brain tissue. The outstanding question was: what are these dividing cells doing?
A crucial observation came from the work of Reynolds and Weiss [2] . They showed that the adult brains of both mice and humans contain stem cells. This was not the first such claim, but they contributed two important factors. The first was a good way of growing the cells. If brain tissue is dissociated and then grown as aggregates, balls of dividing cells appear out the debris of dying neurons and glial cells. The key to generating these 'neurospheres' was the observation that they are stimulated to divide by epidermal growth factor (EGF). Without this factor, all but a handful of nerve cells die -an experiment that must have been done a thousand times over the decades by frustrated neurobiologists. Some of the cells that generate neurospheres must be stem cells, because they have two important properties: they can generate all the neural cell types (except microglia, which are derived from elsewhere), and they are capable of selfreplication. The latter property is the defining capacity that all true stem cells possess, the ability to generate differentiated progeny while leaving behind a stem cell like themselves to respond the next time they are called upon. The second important contribution of Weiss's group, therefore, was to show that the neurosphere-generating cells were truly multipotential stem cells: the cells really did have the potential to replace lost neurons.
The most recent work takes the important step of unifying the observations on the subependyma and the neurospheres. Morshead et al. [3] asked the question 'Are the dividing cells that characterize the subependyma the stem cells that generate the neurospheres?'. The answer turns out to be much more satisfying than any of us had the right to expect. First, the authors show that regions of the brain generate neurospheres in proportion to the number of dividing cells found in that region's subependyma. Also, if you dissect away the subependyma before dissociating the tissue, you get many fewer neurospheres. Almost certainly, therefore, the subependyma is the source of the neurosphere-generating stem cells.
Next, the authors killed these dividing cells in the ependyma using thymidine, and at this point the story takes an interesting twist [3] . They found that within a day of a thymidine kill, the subependyma was almost devoid of dividing cells, yet such tissue when dissociated retained an unimpaired ability to generate neurospheres. The dividing subependymal cells, therefore, could not possibly be the source of the neurospheres. What is that source? Morshead et al. [3] observed that following the thymidine kill, the subependyma recovered, so that the number of dividing cells was back to normal after eight days. There must, therefore, be a precursor of the dividing cells, which survives the thymidine kill (and so cannot be constitutively dividing), yet responds to the killing by generating a new population of dividing cells. To a stem-cell biologist, this has a familiar ring, as true stem cells are quiescent. The dividing cells that seem to dominate the subependyma are probably equivalent to the progenitor cells of other systems. It is only when the progenitor cells are wiped out that the stem cells show themselves. Morshead et al. [3] did a further set of experiments that seem to confirm this interpretation: by killing with thymidine a second time as the putative stem cells were trying to respond, they found that they could compromise the recovery and, significantly, reduce the ability of the tissue to generate neurospheres.
The model is, then, that a population of slow-growing multipotential stem cells generates neurons and glia through the intermediate of proliferative .progenitor cells. Interestingly, not only does this accord quite closely with the situation in other stem-cell systems, such as the skin and bone marrow [1] , it also fits quite well with some of the observations concerning embryonic development -although there is an important difference, as we shall see. The fate of embryonic precursor cells has been studied for some years either by culturing them in isolation or by using a lineage marker such as a retroviral vector. The retroviral work suggested that by late embryogenesis in the cerebral cortex (but not necessarily in other regions), most cells of the ventricular zone are specified to produce a single cell type [4] . They are, therefore, probably equivalent to the progenitor cells described above, with one proviso. Progenitors usually have a 'blast' activity: they undergo fast proliferative division to generate a population of cells quickly. The neuronal progenitors of the embryonic cortex seem to have only modest proliferative capacity, either in vivo or in culture [4] [5] [6] .
So, is there in the embryo an equivalent to the stem cell seen in the adult? The answer, according to a recent paper by Davis and Temple [7] , is yes. By culturing individual precursor cells in isolation, these authors have shown that a single cell can generate neurons, oligodendrocytes and astrocytes -the full complement of cell types -and can also generate more cells that have this capacity, so the cells meet the criterion for selfreplication. Roughly 7 % of precursor cells have this capacity in the Davis and Temple study [7] , although our own work suggests that this might be an underestimate. Using the retroviral labelling technique, which does not require single-cell cloning, we find that at early stages over 50 % of clones are putatively of this type (B.P. Williams and J.P., unpublished observations). Either way, both methods of clonal analysis are in agreement: at early stages of corticogenesis, there is a population of multipotential precursor cells that give way (and presumably give rise) to specified progenitor populations. It is these cells that generate the mature neurons and glia.
Davis and Temple [7] continue a recent practice in their paper by referring to the multipotential embryonic precursor cells as stem cells, and highlighting the self-renewing capacity of these cells. I think both of these tendencies are misleading. The name is mostly a semantic point, but to my mind calling both embryonic and adult cells 'stem cells' obscures the dramatically different functions of the two cell types. The function of the adult stem cell are to lie quiescent, to propagate in response to need, and to self-replicate in order to ensure the survival of the stem-cell population. The function of the embryonic 'stem cell' is quite different: the evidence suggests that this is a proliferative, quickly-dividing cell type, if anything, it is more proliferative than the specified cells it generates. Its primary function, therefore, is expansion. For the same reason, the reference to self-renewal begs the wrong conclusion. Self-renewal is so important in adult stem cells because the function of the cells is to preserve multipotentiality over the lifetime of the animal. The embryonic cells exist to expand themselves rapidly during the exponential growth period of embryogenesis. So, although the embryonic cell type may be transiently self-replicating, this property does not have the significance it has in the adult, where the population has to last for decades. The embryonic populations in the rodent last for less than a week.
But these are merely issues of emphasis. More important is the gratifying correspondence between the embryonic and adult situations, and the unifying model that these studies as a whole suggest. After embryogenesis is complete, the few multipotential precursor cells that remain presumably slip into quiescence, a state from which they emerge only if there is a sudden loss of progenitor cells, such as that generated by the thymidine kill of Morshead et al. [3] . Why the cells do not respond more ably in generating neurons in response to neuronal damage is a mystery. Perhaps there are too few of them. Perhaps the conditions overwhelmingly support the production of glia, rather than neurons -we have known for some time that there are slowly dividing precursor cells that generate glia [8] [9] [10] , although we do not know their relationship to the stem cells discussed here. Perhaps the teleological explanations are correct, and the brain has an in-built mechanism for preventing the generation of more neurons because it would be unable to put them in the right place or wire them up correctly. Whatever the explanation, there is clearly a possibility now for therapeutic intervention leading to the regeneration of neurons, and this is an exciting development indeed.
